<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Demegen, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON
- --------------------------------------------------------------------------------
(Title of Class of Securities)
24804S-10-6
------------------------------
(CUSIP Number)
December 31, 1999
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[_] Rule 13d-1(b) (Qualified Investor)
[_] Rule 13d-1(c) (Passive Investor)
[X] Rule 13d-1(d) (Exempt Investor)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
SCHEDULE 13G
CUSIP NO. 004404109
-----------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
CEO Venture Fund III
IRS Id. No.: 25-1802944
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (a) [_]
(b) [x]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
Membership in any group is disclaimed.
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION:
4
Pennsylvania
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 9,435,000
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
0
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 9,435,000
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
0
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
9,435,000*
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
10
N/A
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
26.4%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTION)
12
PN
- ------------------------------------------------------------------------------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares of Common Stock; and (3) options to
purchase 25,000 shares of Common Stock.
<PAGE>
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON.
1 S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Colker and Newlin Management Associates III
IRS Id. No.: 25-1812983
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (a) [_]
(b) [x]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
Membership in any group is disclaimed.
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION:
4
Pennsylvania
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 0
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
9,435,000**
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 0
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
9,435,000**
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
9,435,000*
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
10
N/A
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
26.4%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTION)
12
PN
- ------------------------------------------------------------------------------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares of Common Stock; and (3) options to
purchase 25,000 shares of Common Stock.
** Shares held by CEO Venture Funds III, a limited partnership of which the
reporting person is general partner. The reporting person disclaims
beneficial ownership of such shares.
2
<PAGE>
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
William R. Newlin
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (a) [_]
(b) [x]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
Membership in any group is disclaimed.
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION:
4
USA
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 0
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
9,435,000**
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 0
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
9,435,000**
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
9,435,000*
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
10
N/A
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
26.4%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTION)
12
IN
- ------------------------------------------------------------------------------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares of Common Stock; and (3) options to
purchase 25,000 shares of Common Stock.
** Shares held by CEO Venture Fund III, a limited partnership whose general
partner is Colker and Newlin Management Associates III of which the reporting
person is managing general partner. The reporting person disclaims beneficial
ownership of such shares.
3
<PAGE>
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
James Colker
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (a) [_]
(b) [x]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
Membership in any group is disclaimed.
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION:
4
USA
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 0
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
9,435,000**
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 0
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
9,435,000**
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
9,435,000*
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
10
N/A
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
26.4%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTION)
12
IN
- ------------------------------------------------------------------------------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares of Common Stock; and (3) options to
purchase 25,000 shares of Common Stock.
** Shares held by CEO Venture Fund III, a limited partnership whose general
partner is Colker and Newlin Management Associates III of which the reporting
person is managing general partner. The reporting person disclaims beneficial
ownership of such shares.
4
<PAGE>
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Gary G. Glausser
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (a) [_]
(b) [x]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
Membership in any group is disclaimed.
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION:
4
USA
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 0
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
0
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 0
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
9,435,000**
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
9,435,000*
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
10
N/A
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
26.4%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTION)
12
IN
- ------------------------------------------------------------------------------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares of Common Stock; and (3) options to
purchase 25,000 shares of Common Stock.
** Shares held by CEO Venture Fund III, a limited partnership whose general
partner is Colker and Newlin Management Associates III of which the reporting
person is a general partner. The reporting person disclaims beneficial
ownership of such shares.
5
<PAGE>
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Eugene R. Yost
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (a) [_]
(b) [x]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
Membership in any group is disclaimed.
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION:
4
USA
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 0
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
0
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 0
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
9,435,000**
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
9,435,000*
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
10
N/A
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
26.4%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTION)
12
IN
- ------------------------------------------------------------------------------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares of Common Stock; and (3) options to
purchase 25,000 shares of Common Stock.
** Shares held by CEO Venture Fund III, a limited partnership whose general
partner is Colker and Newlin Management Associates III of which the reporting
person is a general partner. The reporting person disclaims beneficial
ownership of such shares.
6
<PAGE>
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Glen F. Chatfield
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (a) [_]
(b) [x]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION:
4
USA
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 0
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
0
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 0
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
9,435,000**
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
9,435,000*
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
10
N/A
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
26.4%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTION)
12
IN
- ------------------------------------------------------------------------------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares of Common Stock; and (3) options to
purchase 25,000 shares of Common Stock.
** Shares held by CEO Venture Fund III, a limited partnership whose general
partner is Colker and Newlin Management Associates III of which the reporting
person is a general partner. The reporting person disclaims beneficial
ownership of such shares.
7
<PAGE>
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Ned J. Renzi
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION:
USA
4
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 0
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
0
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 0
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
9,435,000**
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
9,435,000*
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
10
N/A
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
26.4%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
IN
- ------------------------------------------------------------------------------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
Warrant to purchase 4,965,556 shares of Common Stock; and (3) options to
purchase 25,000 shares of Common Stock.
** Shares held by CEO Venture Fund III, a limited partnership whose general
partner is Colker and Newlin Management Associates III of which the reporting
person is a general partner. The reporting person disclaims beneficial
ownership of such shares.
8
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Item 1 (a) Name of Issuer:
Demegen, Inc.
Item 1 (b) Address of issuer's principal executive offices:
1051 Brinton Road
Pittsburgh, PA 15221
Item 2 (a) Name of Person Filing
CEO Venture Fund III
Item 2 (b) Address of principal business office:
c/o CEO Venture Fund
Suite 160
2000 Technologies Drive
Pittsburgh, PA 15219
Item 2 (c) Citizenship or Place of Organization:
Pennsylvania
Item 2 (d) Title of class of securities:
COMMON
Item 2 (e) CUSIP No.
24804S-10-6
Item 3. If this statement is filed pursuant to (S)(S)240.13d-1(b) or
240.13d-2(b) or (c) Check this box Not Applicable.
Item 4. Ownership.
Item 4 (a) Amount beneficially owned:
9,435,000*
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares of Common Stock; and (3) options to
purchase 25,000 shares of Common Stock.
Item 4 (b) Percent of class: 26.4%
Item 4 (c) (i) Sole power to vote: 9,435,000
-------------
(ii) Shared power to vote: -0-
-------------
(iii) Sole power to dispose: 9,435,000
-------------
(iv) Shared power to dispose -0-
-------------
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable
9
<PAGE>
Item 6 Ownership of more than 5 percent on behalf of another
person:
Not Applicable
Item 7 Identification and classification of subsidiary:
Not Applicable
Item 8 Identification and classification of members of
the group:
Not Applicable
Item 9 Notice of dissolution of the group:
Not Applicable
Item 10 Certification:
Materials to be Filed as Exhibits
---------------------------------
Exhibit 1 Agreement between the reporting persons
with respect to the filing of this Schedule 13G.
10
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Item 1 (a) Name of Issuer:
Demegen, Inc.
Item 1 (b) Address of issuer's principal executive offices:
1051 Brinton Road
Pittsburgh, PA 15221
Item 2 (a) Name of Person Filing
Colker and Newlin Management Associates III
Item 2 (b) Address of principal business office:
c/o CEO Venture Fund
Suite 160
2000 Technologies Drive
Pittsburgh, PA 15219
Item 2 (c) Citizenship or Place of Organization:
Pennsylvania
Item 2 (d) Title of class of securities:
COMMON
Item 2 (e) CUSIP No.
24804S-10-6
Item 3. If this statement is filed pursuant to (S)(S)240.13d-1(b) or
240.13d-2(b) or (c) Check this box
Not Applicable.
Item 4. Ownership.
Item 4 (a) Amount beneficially owned:
9,435,000*
---------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares of Common Stock; and (3) options to
purchase 25,000 shares of Common Stock.
Item 4 (b) Percent of class:
26.4%
Item 4 (c) (i) Sole power to vote:
9,435,000
(ii) Shared power to vote:
9,435,000**
(iii) Sole power to dispose:
0
(iv) Shared power to dispose
9,435,000**
11
<PAGE>
** Shares held by CEO Venture Fund III, a limited partnership of which the
reporting person is general partner. The reporting person disclaims
beneficial ownership of such shares.
Item 5 Ownership of 5 percent or less of a class:
Not Applicable
Item 6 Ownership of more than 5 percent on behalf of another
person:
Not Applicable
Item 7 Identification and classification of subsidiary:
Not Applicable
Item 8 Identification and classification of members of
the group:
Not Applicable
Item 9 Notice of dissolution of the group:
Not Applicable
Item 10 Certification:
Materials to be Filed as Exhibits
---------------------------------
Exhibit 1 Agreement between the reporting persons
with respect to the filing of this Schedule 13G.
12
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Item 1
(a) Name of Issuer
Demegen, Inc.
(b) Address of Issuer's Principal Executive Offices
1051 Brinton Road
Pittsburgh, PA 15221
Item 2
(a) Name of Person Filing
William R. Newlin
(b) Address of Principal Business Office:
c/o CEO Venture Fund
Suite 160
2000 Technologies Drive
Pittsburgh, PA 15219
(c) Citizenship:
USA
(d) Title of Class of Securities:
COMMON
(e) CUSIP Number.:
24804S-10-6
Item 3 If this statement is filed pursuant to 240.13d-1(b) or 13d-
2(b) or (c) check this box Not Applicable
Item 4 Ownership.
(a) Amount beneficially owned:
9,435,000*
----------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares Common Stock; and (3) options to purchase
25,000 shares of Common Stock.
(b) Percent of class:
26.4%
13
<PAGE>
Item 4
(c) (i) sole power to vote: 0
---------
(ii) shared power to vote: 9,435,000**
---------
(iii) sole power to dispose: 0
---------
(iv) Shared power to dispose: 9,435,000**
---------
** Shares held by CEO Venture Fund III, a limited partnership whose general
partner is Colker and Newlin Management Associates III of which the
reporting person is managing general partner. The reporting person disclaims
beneficial ownership of such shares.
Item 5 Ownership of 5 percent or less of a class:
Not Applicable
Item 6 Ownership of more than 5 percent on behalf of another
person:
Not Applicable
Item 7 Identification and classification of subsidiary:
Not Applicable
Item 8 Identification and classification of members of
the group:
Not Applicable
Item 9 Notice of dissolution of the group:
Not Applicable
Item 10 Certification:
Materials to be Filed as Exhibits
---------------------------------
Exhibit 1 Agreement between the reporting persons
with respect to the filing of this Schedule 13G.
14
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Item 1
(a) Name of Issuer
Demegen, Inc.
(b) Address of Issuer's Principal Executive Offices
1051 Brinton Road
Pittsburgh, PA 15221
Item 2
(a) Name of Person Filing
James Colker
(b) Address of Principal Business Office:
c/o CEO Venture Fund
Suite 160
2000 Technologies Drive
Pittsburgh, PA 15219
(c) Citizenship:
USA
(d) Title of Class of Securities:
COMMON
(e) CUSIP Number.:
24804S-10-6
Item 3 If this statement is filed pursuant to 240.13d-1(b) or 13d-
2(b) or (c) check this box Not Applicable
Item 4 Ownership.
(a) Amount beneficially owned:
9,435,000*
----------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares Common Stock; and (3) options to purchase
25,000 shares of Common Stock.
(b) Percent of class:
26.4%
15
<PAGE>
Item 4
(c) (i) sole power to vote: 0
---------
(ii) shared power to vote: 9,435,000**
---------
(iii) sole power to dispose: 0
---------
(iv) Shared power to dispose: 9,435,000**
---------
** Shares held by CEO Venture Fund III, a limited partnership whose general
partner is Colker and Newlin Management Associates III of which the
reporting person is managing general partner. The reporting person disclaims
beneficial ownership of such shares.
Item 5 Ownership of 5 percent or less of a class:
Not Applicable
Item 6 Ownership of more than 5 percent on behalf of another
person:
Not Applicable
Item 7 Identification and classification of subsidiary:
Not Applicable
Item 8 Identification and classification of members of
the group:
Not Applicable
Item 9 Notice of dissolution of the group:
Not Applicable
Item 10 Certification:
Materials to be Filed as Exhibits
---------------------------------
Exhibit 1 Agreement between the reporting persons
with respect to the filing of this Schedule 13G.
16
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Item 1
(a) Name of Issuer
Demegen, Inc.
(b) Address of Issuer's Principal Executive Offices
1051 Brinton Road
Pittsburgh, PA 15221
Item 2
(a) Name of Person Filing
Gary G. Glausser
(b) Address of Principal Business Office:
c/o CEO Venture Fund
Suite 160
2000 Technologies Drive
Pittsburgh, PA 15219
(c) Citizenship:
USA
(d) Title of Class of Securities:
COMMON
(e) CUSIP Number.:
24804S-10-6
Item 3 If this statement is filed pursuant to 240.13d-1(b) or 13d-
2(b) or (c) check this box Not Applicable
Item 4 Ownership.
(a) Amount beneficially owned:
9,435,000*
----------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares Common Stock; and (3) options to purchase
25,000 shares of Common Stock.
(b) Percent of class:
26.4%
17
<PAGE>
Item 4
(c) (i) sole power to vote: 0
---------
(ii) shared power to vote: 0
---------
(iii) sole power to dispose: 0
---------
(iv) Shared power to dispose: 9,435,000**
---------
** Shares held by CEO Venture Fund III, a limited partnership whose general
partner is Colker and Newlin Management Associates III of which the
reporting person is managing general partner. The reporting person disclaims
beneficial ownership of such shares.
Item 5 Ownership of 5 percent or less of a class: Not Applicable
Item 6 Ownership of more than 5 percent on behalf of another
person:
Not Applicable
Item 7 Identification and classification of subsidiary:
Not Applicable
Item 8 Identification and classification of members of
the group:
Not Applicable
Item 9 Notice of dissolution of the group:
Not Applicable
Item 10 Certification:
Materials to be Filed as Exhibits
---------------------------------
Exhibit 1 Agreement between the reporting persons
with respect to the filing of this Schedule 13G.
18
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Item 1 (a) Name of Issuer:
Demegen, Inc.
Item 1 (b) Address of issuer's principal executive offices:
1051 Brinton Road
Pittsburgh, PA 15221
Item 2 (a) Name of Person Filing:
Eugene R. Yost
Item 2 (b) Address of Principal Business Office:
c/o CEO Venture Fund
Suite 160
2000 Technologies Drive
Pittsburgh, PA 15219
Item 2 (c) Citizenship:
USA
Item 2 (d) Title of Class of Securities:
COMMON
Item 2 (e) CUSIP No.:
24804S-10-6
Item 3 If this statement is filed pursuant to (S)(S)240.13d-1(b) or
240.13d-2(b) or (c), check this box
Not Applicable
Item 4 Ownership.
Item 4 (a) Amount beneficially owned:
9,435,000*
----------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares of Common Stock; and (3) options to
purchase 25,000 shares of Common Stock.
Item 4 (b) Percent of class:
26.4%
19
<PAGE>
Item 4 (c) (i) Sole power to vote: 0
-----
(ii) Shared power to vote: 0
-----
(iii) Sole power to dispose: 0
---------
(iv) Shared power to dispose: 9,435,000**
---------
** Shares held by CEO Venture Fund III, a limited partnership whose general
partner is Colker and Newlin Management Associates III of which the
reporting person is a general partner. The reporting person disclaims
beneficial ownership of such shares.
Item 5. Ownership of 5 percent or less of a class:
Not Applicable
Item 6. Ownership of more than 5 Percent on behalf of another
person:
Not Applicable
Item 7. Identification and classification of subsidiary:
Not Applicable
Item 8. Identification and classification of members of
the group:
Not Applicable
Item 9. Notice of dissolution of the group:
Not Applicable
Item 10. Certification:
Materials to be Filed as Exhibits
---------------------------------
Exhibit 1 Agreement between the reporting persons
with respect to the filing of this Schedule 13G.
20
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Item 1 (a) Name of Issuer:
Demegen, Inc.
Item 1 (b) Address of issuer's principal executive offices:
1051 Brinton Road
Pittsburgh, PA 15221
Item 2 (a) Name of Person Filing:
Glen F. Chatfield
Item 2 (b) Address of Principal Business Office:
c/o CEO Venture Fund
Suite 160
2000 Technologies Drive
Pittsburgh, PA 15219
Item 2 (c) Citizenship:
USA
Item 2 (d) Title of Class of Securities:
COMMON
Item 2 (e) CUSIP No.:
24804S-10-6
Item 3 If this statement is filed pursuant to (S)(S)240.13d-1(b) or
240.13d-2(b) or (c), check this box
Not Applicable
Item 4 Ownership.
Item 4 (a) Amount beneficially owned:
9,435,000*
----------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares of Common Stock; and (3) options to
purchase 25,000 shares of Common Stock.
Item 4 (b) Percent of class:
26.4%
21
<PAGE>
Item 4 (c) (i) Sole power to vote: 0
-----
(ii) Shared power to vote: 0
-----
(iii) Sole power to dispose: 0
---------
(iv) Shared power to dispose: 9,435,000**
---------
** Shares held by CEO Venture Fund III, a limited partnership whose general
partner is Colker and Newlin Management Associates III of which the
reporting person is a general partner. The reporting person disclaims
beneficial ownership of such shares.
Item 5. Ownership of 5 percent or less of a class:
Not Applicable
Item 6. Ownership of more than 5 Percent on behalf of another
person:
Not Applicable
Item 7. Identification and classification of subsidiary:
Not Applicable
Item 8. Identification and classification of members of
the group:
Not Applicable
Item 9. Notice of dissolution of the group:
Not Applicable
Item 10. Certification:
Materials to be Filed as Exhibits
---------------------------------
Exhibit 1 Agreement between the reporting persons
with respect to the filing of this Schedule 13G.
22
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Schedule 13G
Under the Securities Exchange Act of 1934
Item 1 (a) Name of Issuer:
Demegen, Inc.
Item 1 (b) Address of issuer's principal executive offices:
1051 Brinton Road
Pittsburgh, PA 15221
Item 2 (a) Name of Person Filing:
Ned J. Renzi
Item 2 (b) Address of Principal business office:
c/o CEO Venture Fund
Suite 160
2000 Technologies Drive
Pittsburgh, PA 15219
Item 2 (c) Citizenship:
USA
Item 2 (d) Title of Class of Securities:
COMMON
Item 2 (e) CUSIP No.:
24804s-10-6
Item 3 If this statement is filed pursuant to (S)(S)240.13d-1(b) or
240.13d-2(b) or (c), check this box
Not Applicable
Item 4 Ownership.
Item 4 (a) Amount beneficially owned:
9,435,000*
----------
* The amount beneficially owned includes: (1) 4,444,444 shares of Convertible
Preferred Stock convertible into 4,444,444 shares of Common Stock; (2) a
warrant to purchase 4,965,556 shares of Common Stock; and (3) options to
purchase 25,000 shares of Common Stock.
Item 4 (b) Percent of class:
26.4%
23
<PAGE>
Item 4 (c) (i) Sole power to vote: 0
-----
(ii) Shared power to vote: 0
-----
(iii) Sole power to dispose: 0
---------
(iv) Shared power to dispose: 9,435,000**
---------
** Shares held by CEO Venture Fund III, a limited partnership whose general
partner is Colker and Newlin Management Associates III of which the
reporting person is a general partner. The reporting person disclaims
beneficial ownership of such shares.
Item 5. Ownership of 5 percent or less of a class:
Not Applicable
Item 6. Ownership of more than 5 Percent on behalf of another
person:
Not Applicable
Item 7. Identification and classification of subsidiary:
Not Applicable
Item 8. Identification and classification of members of
the group:
Not Applicable
Item 9. Notice of dissolution of the group:
Not Applicable
Item 10. Certification:
Materials to be Filed as Exhibits
---------------------------------
Exhibit 1 Agreement between the reporting persons
with respect to the filing of this Schedule 13G.
24
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of their knowledge and belief, each
of the undersigned certifies that the information set forth in this statement is
true, complete and correct.
CEO VENTURE FUND III
Date: February 11, 2000 By: COLKER AND NEWLIN
MANAGEMENT ASSOCIATES III,
GENERAL PARTNER
By: /s/ James Colker
------------------------
James Colker
Managing General Partner
COLKER AND NEWLIN
MANAGEMENT ASSOCIATES III
Date: February 11, 2000 By: /s/ James Colker
------------------------
James Colker
Managing General Partner
WILLIAM R. NEWLIN
Date: February 11, 2000 By: /s/ William R. Newlin
------------------------
William R. Newlin
JAMES COLKER
Date: February 11, 2000 By: /s/ James Colker
------------------------
James Colker
25
<PAGE>
GARY G. GLAUSSER
Date: February 11, 2000 By: /s/ Gary G. Glausser
-----------------------
Gary G. Glausser
EUGENE R. YOST
Date: February 11, 2000 By: /s/ Eugene R. Yost
-----------------------
Eugene R. Yost
GLEN F. CHATFIELD
Date: February 11, 2000 By: /s/ Glen F. Chatfield
-----------------------
Glen F. Chatfield
NED J. RENZI
Date: February 11, 2000 By: /s/ Ned J. Renzi
-----------------------
Ned J. Renzi
26
<PAGE>
EXHIBIT INDEX
-------------
EXHIBIT NO. DESCRIPTION PAGE
- ---------- ----------- ----
1 Agreement between the Reporting Persons with
respect to the filing of this Schedule 13G 28
27
<PAGE>
EXHIBIT 1
---------
We, the undersigned, hereby express our agreement that the attached Schedule
13G is filed on behalf of each of the undersigned.
CEO VENTURE FUND III
Date: February 11, 2000 BY: COLKER AND NEWLIN
MANAGEMENT ASSOCIATES III,
GENERAL PARTNER
By: /s/ James Colker
------------------------
James Colker
Managing General Partner
COLKER AND NEWLIN
MANAGEMENT ASSOCIATES III
Date: February 11, 2000 By: /s/ James Colker
------------------------
James Colker
Managing General Partner
WILLIAM R. NEWLIN
Date: February 11, 2000 By: /s/ William R. Newlin
------------------------
William R. Newlin
JAMES COLKER
Date: February 11, 2000 By: /s/ James Colker
------------------------
James Colker
28
<PAGE>
GARY G. GLAUSSER
Date: February 11, 2000 By: /s/ Gary G. Glausser
----------------------
Gary G. Glausser
EUGENE R. YOST
Date: February 11, 2000 By: /s/ Eugene R. Yost
----------------------
Eugene R. Yost
GLEN F. CHATFIELD
Date: February 11, 2000 By: /s/ Glen F. Chatfield
----------------------
Glen F. Chatfield
NED J. RENZI
Date: February 11, 2000 By: /s/ Ned J. Renzi
----------------------
Ned J. Renzi
29
